In vitro treatment of HEp-2 cells with human tumor necrosis factor-alpha and human interferons reduces invasiveness of Salmonella typhimurium.

J Biol Regul Homeost Agents

Kapt. W. Wilhelmsen og frues Bakteriologiske Institutt, Rikshospitalet, University of Oslo, Norway.

Published: July 1989

Enteroinvasive bacteria, like Salmonella typhimurium, can be internalized in in vitro cultured epithelioidal cells, like HEp-2 cells. This phenomenon is inhibited by pretreatment of cells with human tumor necrosis factor alpha (TNF-alpha) in a dose- and time-dependent manner. The effect was also reproduced in other cell types, including diploid embryo fibroblast cells. The TNF-alpha effect was neutralized by anti-TNF-alpha antibodies. No synergistic effect was produced by combinations of TNF-alpha with either interferon alpha or gamma. Unlike the effects of interferons, TNF-alpha inhibited the invasiveness of Shigella flexneri and the TNF-alpha effect was not inhibited by cycloheximide.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hep-2 cells
8
cells human
8
human tumor
8
tumor necrosis
8
salmonella typhimurium
8
tnf-alpha inhibited
8
cells
5
tnf-alpha
5
vitro treatment
4
treatment hep-2
4

Similar Publications

Effects of Environment Regulating T4SS on Virulence and Adaptability of Streptococcus suis.

Environ Res

January 2025

College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China; Henan Engineering Research Center of Livestock and Poultry Emerging Disease Detection and Control, Luoyang, China. Electronic address:

Streptococcus suis (S. suis) represents a significant bacterial pathogen, with its zoonotic transmission from infected or deceased pigs to humans posing a serious threat to public health. The type IV secretion system (T4SS), a critical virulence factor of S.

View Article and Find Full Text PDF

Fumarprotocetraric acid and geraniin were identified as novel inhibitors of human respiratory syncytial virus infection .

Front Cell Infect Microbiol

January 2025

State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Introduction: Respiratory syncytial virus (RSV) remains a major international public health concern. However, disease treatment is limited to preventive care with monoclonal antibodies and supportive care. In this study, natural products were screened to identify novel anti-RSV inhibitors.

View Article and Find Full Text PDF

The global burden of respiratory syncytial virus (RSV) and severe associated disease is prodigious. RSV-specific vaccines have been launched recently but there is no antiviral medicine commercially available. RSV polymerase (L) protein is one of the promising antiviral targets, along with fusion and nucleocapsid proteins.

View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is one of the most prevalent viruses that causes severe acute lower respiratory tract infections (ALRTIs) in the elderly and young children. There is no specific drug to treat RSV, only a broad-spectrum antiviral, ribavirin, which is only used in critical cases. Our research group is investigating antiviral agents of natural origin, such as coumarins and flavonoids, that may help reduce or prevent RSV infection.

View Article and Find Full Text PDF

New haloaminopyrazole derivatives differing in the number of pyrazole nuclei - and -, respectively, were synthesized and characterized by H-NMR, C-NMR, IR, UV-Vis, and elemental analysis. The single-crystal X-ray diffraction method was used to describe compounds and . When tested on normal NCTC fibroblasts in vitro, the newly synthesized derivatives were shown to be non-cytotoxic at a dosage of 25 μg/mL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!